Richard James Houghton, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 949 W Grassland Dr, Highland, UT 84003 Phone: 801-492-1123 Fax: 801-492-0960 |
Alpine Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11038 N. Highland Blvd, Suite 200, Highland, UT 84003 Phone: 801-756-7150 Fax: 801-642-0938 |
Steven J Weaver, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 11038 Highland Blvd Ste 300, Highland, UT 84003 Phone: 801-756-7150 Fax: 801-642-0938 |
Dr. Bruce T Potts, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5455 W 11000 N Ste 101, Highland, UT 84003 Phone: 801-756-9357 |
Timpanogos Vision Center Optometrist Medicare: Medicare Enrolled Practice Location: 5455 W 11000 N, Suite 101, Highland, UT 84003 Phone: 801-756-9357 Fax: 801-756-9358 |
Dr. Kevin Jay Fromm, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5455 W 11000 N, Suite 101, Highland, UT 84003 Phone: 801-756-9357 Fax: 801-756-9358 |
Highland Office Sub-part Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5455 W 11000 N, Suite 101, Highland, UT 84003 Phone: 801-756-9357 Fax: 801-756-9358 |
Alpine Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11038 Highland Blvd, #300, Highland, UT 84003 Phone: 801-756-7150 Fax: 801-642-0938 |
News Archive
A recent study shows that one in five children in the UK have a higher risk of developing adolescent mental health disorders or physical illness because of persistent poverty. This alarming scenario comes from a new paper published in the Archives of Disease in Childhood.
CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of the Bullseye™ Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and PCL) reconstructions of the knee.
Abraxis BioScience, Inc. announced today that findings from their phase 3 randomized trial of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension) plus carboplatin, showed a statistically significant 31 percent improvement in overall response rate when compared with Taxol (paclitaxel) injection plus carboplatin in the first-line treatment of patients with non-small cell lung cancer.
A team of Florida State University researchers will use a five-year, $1.3 million grant from the National Institutes of Health to develop a way to measure levels of the trace metal zinc in the human body.
› Verified 4 days ago